32 COUNTRIES HAVE APPROVED THIS DRUG FOR USE WITH MS AND THE MOST ADVANCED COUNTRY IN THE WORLD IS NOT ALLOWING ACCESS TO A MEDICATION THAT WOULD GREATLY BENEFIT THOSE SUFFERING WITH THE MOST DEBILITATING NEUROLOGICAL DISORDER OF YOUNG ADULTS. ACT IN THE CASE OF AMERICANS WHO SUFFER WITH MULTIPLE SCLEROSIS AND PRESSURE THE FDA TO APPROVE THIS DRUG



